{"data":{"responsecode":"000","responsemsg":"","quote":{"hi":"75.450","rs_stock_flag":false,"fiscal_year_end":"","hist_closedate":"","replication_method":null,"amt_os":"161,690,510","primaryexch":"HKEX","ric":"6938.HK","product_subtype":null,"db_updatetime":"09 Jan 2026 09:36","mkt_cap_u":"B","am_u":"M","ew_sub_right":"","secondary_listing":false,"ew_amt_os_cur":null,"ccy":"HKD","management_fee":"","ew_underlying_code":null,"trdstatus":"N","nav":"","original_offer_price":"","issue":"","asset_class":null,"eps":null,"inline_upper_strike_price":"","sedol":"BVK63M7","am":"549.86","iv":"","ew_strike":"","as":"70.450","geographic_focus":null,"incorpin":"PRC","etp_baseCur":null,"ew_amt_os":"","bd":"70.400","registrar":"Computershare Hong Kong Investor Services Ltd.","depositary":null,"exotic_type":null,"callput_indicator":null,"primary_market":null,"underlying_index":null,"lot":"200","update_time":"2026-01-09 01:36:34.0","lo52":"","shares_issued_date":"9 Jan 2026","premium":"","strike_price_ccy":null,"yield":"","vo_u":"M","base_currency":null,"coupon":"","expiry_date":"","chairman":"Liang Zicai","underlying_ric":"6938.HK","hi52":"","issuer_name":"Suzhou Ribo Life Science Co., Ltd. - B - H Shares","h_share_flag":false,"ew_sub_per_from":"","div_yield":"","interest_payment_date":"-","updatetime":"09 Jan 2026 10:27","aum_date":"","lo":"65.900","mkt_cap":"11.39","f_aum_hkd":null,"ew_sub_per_to":"","ls":"70.450","nav_date":"","csic_classification":null,"floating_flag":false,"issued_shares_note":null,"nom_ccy":null,"eff_gear":"","board_lot_nominal":null,"hsic_ind_classification":"Healthcare - Pharmaceuticals & Biotechnology","ew_desc":null,"inception_date":"","nc":"0","aum":"","issued_shares_class_B":null,"vo":"7.60","secondary_listing_flag":false,"listing_date":"9 Jan 2026","issued_shares_class_A":null,"as_at_label":"as at","ew_amt_os_dat":"","nm":"Suzhou Ribo Life Science Co., Ltd. - B - H Shares","nm_s":"RIBOLIFE-B","sym":"6938","inline_lower_strike_price":"","listing_category":"Primary Listing","ew_strike_cur":null,"exotic_warrant_indicator":null,"investment_focus":null,"call_price":"","tck":"0.050","strike_price":"","summary":"Suzhou Ribo Life Science Co Ltd is a China-based company primarily engaged in the oligonucleotide research and development, with a focus on small interfering ribonucleic acid (siRNA) therapeutics. The Company’s main business is engaged in the oligonucleotide drug innovation focused on cardiovascular, metabolic, renal and liver diseases, as well as other therapeutic areas. The Company’s drug pipelines include RBD4059, RBD5044, RBD7022, RBD7007, RBD2080, RBD1119, RBD1016 and others. The Company mainly conducts its business in the domestic market.","op":"75.000","aum_u":"","nav_ccy":null,"class_B_description":null,"os":"","wnt_gear":"","transfer_of_listing_date":"","hsic_sub_sector_classification":"Biotechnology","amt_ccy":null,"class_A_description":null,"domicile_country":null,"entitlement_ratio":"","product_type":"EQTY","office_address":"No. 168 Yuanfeng Road<br/>Yushan Town<br/>Kunshan City<br/>Jiangsu Province, PRC","pc":"0.00","days_to_expiry":null,"underlying_code":null,"pe":"","eps_ccy":null,"hdr":false,"launch_date":"","hc":"","isin":"CNE100007DS6","moneyness":""}},"qid":"1767926563458"}
